Evidence map›Paper›PMID 33891474›Full record

SynthesisJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Association of Germline BRCA Pathogenic Variants With Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data.

Volkan Turan, Matteo Lambertini, Dong-Yun Lee, Erica Wang, Florian Clatot, Beth Y Karlan, Isabelle Demeestere, Heejung Bang, Kutluk Oktay

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. [Fertility management in breast cancer patients: current strategies and research advances].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2025
    Review
  12. Review
  13. Addressing the Needs of Breast Cancer Survivors.Current oncology reports · 2025
    Review
  14. Review
  15. Clinical Behavior of Breast Cancer in YoungJournal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
  16. Article
  17. Susceptibility of Brca1Cancer science · 2025
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 5 countries.

Volkan TuranDepartment of Obstetrics and Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT.
Matteo LambertiniDepartment of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.ORCID 0000-0003-1797-5296
Dong-Yun LeeDepartment of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.ORCID 0000-0002-7540-0522
Erica WangDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA.
Florian ClatotDepartment of Medical Oncology, Henri Becquerel Centre, Rouen, France.ORCID 0000-0002-7074-9282
Beth Y KarlanUCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA.ORCID 0000-0002-9451-2933
Isabelle DemeestereFertility Clinic, Research Laboratory on Human Reproduction, CUB-Erasme, and Université Libre de Bruxelles (ULB), Brussels, Belgium.ORCID 0000-0002-3192-6565
Heejung BangDivision of Biostatistics, Department of Public Health Sciences, University of California, Davis, CA.ORCID 0000-0002-5755-9951
Kutluk OktayDepartment of Obstetrics and Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT.ORCID 0000-0003-0914-7757
Yale University · USCedars-Sinai Medical Center · USOspedale Policlinico San Martino · ITSamsung Medical Center · KRUCLA Jonsson Comprehensive Cancer CenterUniversité Libre de Bruxelles · BEUniversity of California, Davis · US

Funding

UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
Characterization & Prevention of Chemotherapy-Induced Damage to Ovarian ReserveR01HD053112 · NICHD · YALE UNIVERSITY · PI KUTLUK H OKTAY · 2007 to 2026
$7.6M
NCATS NIH HHS UL1 TR001860NICHD NIH HHS R01 HD053112
6 · The paper itself

Abstract

purposeTo determine whether germline MATERIALS AND

methodsAn individual patient-level data meta-analysis was performed using five data sets on 828 evaluable women who were tested for g

resultsThe mean age of women with versus without g

conclusionYoung women with g

Indexed as

Germ-Line MutationAdultAnti-Mullerian HormoneBRCA1 ProteinBRCA2 ProteinBreast NeoplasmsCase-Control StudiesFemaleHumansOvarian ReserveAnti-Mullerian HormoneBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, human

Identifiers

PMID33891474
PMCPMC8260903
OpenAlexW3131144956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.